What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant? [PDF]
Kodjikian L +4 more
europepmc +1 more source
Stabilizing Macular Edema Fluctuations: Outcomes of Intravitreal Fluocinolone Acetonide for Diabetic Macular Edema and Non-Infectious Uveitis. [PDF]
Hohberger B +3 more
europepmc +1 more source
Intravitreal Corticosteroids in the Management of Refractory Macular Edema in Birdshot Chorioretinopathy. [PDF]
Alves Ambrósio J +5 more
europepmc +1 more source
The Incidence of Post-Operative Fibrinoid Syndrome in Diabetic Eyes Receiving a Dexamethasone Implant During Pars Plana Vitrectomy Surgery. [PDF]
ElSheikh R +5 more
europepmc +1 more source
Suprachoroidal Delivery of Corticosteroid Slow-Release Implants for the Treatment of Cystoid Macular Edema. [PDF]
Asani B +3 more
europepmc +1 more source
Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study. [PDF]
Ruiz-Medrano J +12 more
europepmc +1 more source
Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]
Pleyer U +9 more
europepmc +1 more source
Real-World Data on Morphological and Functional Responses After Switching to Faricimab in Recalcitrant, Chronic Diabetic Macular Edema. [PDF]
Deiters V +6 more
europepmc +1 more source
A Case of Persistent Bilateral Irvine-Gass Syndrome Following Uneventful Cataract Surgery in a Healthy Individual. [PDF]
Low CS +3 more
europepmc +1 more source
Intravitreal steroid implants in the management of noninfectious intermediate and posterior uveitis. [PDF]
Shah SM, Prabhu P, Biswas J.
europepmc +1 more source

